首页> 外文OA文献 >Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial

【2h】

Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial

机译：随机对照甲尾甲醇三甲产蛋白，长霉素，多柔比星和顺铂（DD-MVAC）或吉西他滨和顺铂（GC）的患者为膀胱局部晚期过渡细胞癌患者的患者的随机致密甲氨蝶呤（DD-MVAC）或吉西他滨和顺铂（GC）的设计。法国Getug / AFU V05 Vesper试用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Christian Pfister; Valentin Harter; Yves Allory; François Radvanyi; Stéphane Culine; G. Grawis; G. Pignot; A. Flechon; J.P. Fendler; C. Chevreau; M. Soulie; H. Mahammedi; L. Guy; B. Laguerre; G. Verhoest; A. Guillot; N. Mottet; F. Joly; A. Doerfler; S. Abadie-Lacourtoisie; A.R. Azzouzi; P. Mongiat; L. Geoffrois; P. Eschwege; F. Di Fiore; G. Roubaud; J.L. Hoepffner; P. Barthelemy; H. Lang; E. Voog; E. Mandron; J.M. Tourani; C. Serrrate; A. Colau; C. Saldana; A. de La Taille; T. Nguyen; F. Kleinclauss; Y. Loriot; J. Irani; J.C. Eymard; S. Larre; O. Huillard; M. Zerbib; F. Rolland; J. Rigaud; N. Houede; S. Droupy; G. Malouf; M. Roupret; M. El Demery; C. Legon; S. Vieillot; N. Letang; T. Lharidon; N. Gaschignard; W. Hilgers; J.L. Davin;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial [J] . Christian Pfister, Valentin Harter, Yves Allory, Contemporary Clinical Trials Communications . 2020,第4期

机译：随机对照甲尾甲醇三甲产蛋白，长霉素，多柔比星和顺铂（DD-MVAC）或吉西他滨和顺铂（GC）的患者为膀胱局部晚期过渡细胞癌患者的患者的随机致密甲氨蝶呤（DD-MVAC）或吉西他滨和顺铂（GC）的设计。法国Getug / AFU V05 Vesper试用
2. Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer [J] . J. T. Roberts, H. von der Maase, L. Sengeløv, Annals of Oncology . 2006,第suppla5期

机译：比较吉西他滨/顺铂和甲氨蝶呤/长春碱/阿霉素/顺铂在局部晚期和转移性膀胱癌患者中的随机试验的长期生存结果
3. Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. [J] . De Santis M, Bellmunt J, Mead G, Journal of Clinical Oncology . 2012,第2期

机译：II / III期随机试验评估吉西他滨/卡铂和甲氨蝶呤/卡铂/长春碱对不适合顺铂化疗的晚期尿路上皮癌患者：EORTC研究30986。
4. Design of a randomized controlled phase III study of dose dense methotrexate vinblastine doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial [O] . Christian Pfister, Valentin Harter, Yves Allory, 2020

机译：剂量密集的甲氨蝶呤长春碱阿霉素和顺铂（dd-MVAC）或吉西他滨和顺铂（GC）作为围手术期化疗的局部晚期膀胱癌患者的随机对照III期研究设计。法国GETUG / AFU V05 VESPER试用版
5. Randomized Phase II/III Trial Assessing Gemcitabine/ Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy: Phase II—Results of EORTC Study 30986 [O] . De Santis, Maria, Bellmunt, Joaquim, Mead, Graham, 2009

机译：晚期吉林他滨/卡铂和甲氨蝶呤/甲氨蝶呤/卡铂/长春碱对不适合顺铂化疗的晚期尿路上皮癌患者的II / III期随机试验：II期-EORTC研究30986的结果

著录项

引文网络

相似文献

相关主题

期刊订阅